Assemblify have developed a platform technology that improves the production of cerebral organoids (‘mini-brains’ which are lab-grown human brain tissue). These can be used for the investigation of neurological conditions such as brain cancer and Alzheimer’s Disease; as well as for use in applications related to drug discovery screens (such as cancer, dementia, epilepsy).